glp-1 timeline Another milestone in the evolution of GLP-1-based diabetes therapies Timeline of GLP-1 discovery and

DallOlio FG, Rizzo A, and Mollica V, et al (2021) Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis Immunotherapy 13 (3):257270 76

The majority of drug-induced pancreatitis cases are mild to moderate in severity

Furthermore, the effects of AP39 on mitochondrial activity are concentration-dependent

"Use of ger Page 518 and 519: Weinmann W, Renz M, Vogt S, and Pol Page 520 and 521: Wenzel A, Nendza M, Hartmann P, and Page 522 and 523: 7799(00)01541-9

stay hydrated

What surprised researchers the most is that not only do these work to control type two diabetes, they also help people with obesity lose weight like nothing else really ever has